TCN 237 dihydrochloride

Discontinued Product

4072 has been discontinued.

View all NMDA Receptors products.
Description: Highly potent and selective GluN2B NMDA antagonist
Chemical Name: 2-[[4-[(2-Fluorophenyl)methyl]-1-piperidinyl]methyl]-1H-benzimidazol-6-ol dihydrochloride
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (5)

Biological Activity for TCN 237 dihydrochloride

TCN 237 dihydrochloride is a highly potent GluN2B (formally NR2B) selective NMDA receptor antagonist (Ki = 0.8 nM); blocks GluN2B-mediated calcium influx in Ltk cells (Ki = 9.7 nM). Selective for GluN2B subunit over α1-adrenergic receptors and hERG channels (IC50 values are 730 nM and 2900 nM respectively). Displays efficacy in the rat carrageenan-induced mechanical hyperalgesia assay.

Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.

Technical Data for TCN 237 dihydrochloride

M. Wt 412.33
Formula C20H22FN3O.2HCl
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 700878-19-9
PubChem ID 90488908
InChI Key JYUWGWCFJMDMND-UHFFFAOYSA-N
Smiles FC1=CC=CC=C1CC(CC4)CCN4CC3=NC2=CC=C(O)C=C2N3.Cl.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for TCN 237 dihydrochloride

References for TCN 237 dihydrochloride

References are publications that support the biological activity of the product.

McCauley et al (2004) NR2B-selective N-MthD.-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles. J.Med.Chem. 47 2089 PMID: 15056006

View Related Products by Target

View Related Products by Product Action

View all NMDA Receptor Antagonists

Keywords: TCN 237 dihydrochloride, TCN 237 dihydrochloride supplier, TCN237, dihydrochloride, NR2B, NMDA, antagonists, highly, potent, selective, analgesic, in, vivo, GluN2B, Receptors, 4072, Tocris Bioscience

Citations for TCN 237 dihydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for TCN 237 dihydrochloride.

Reviews for TCN 237 dihydrochloride

There are currently no reviews for this product. Be the first to review TCN 237 dihydrochloride and earn rewards!

Have you used TCN 237 dihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells
Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Huntington's Disease Poster

Huntington's Disease Poster

Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.